Skip to content

Trial to evaluate the assistance of surgery by visualizing the urinary tract using a fluorescent substance called indocyanine green during robot-assisted laparoscopic radical prostatectomy

Exploratory trial on the efficacy of intravesical indocyanine green (ICG) administration in robot-assisted laparoscopic radical prostatectomy - RAPIU Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs031240298
Enrollment
6
Registered
2024-08-26
Start date
2024-10-23
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Cancer Prostate Cancer

Interventions

A diluted solution of ICG) (2 mg/100 ml) is injected into the urinary tract through a urethral catheter filled with saline, and observed using the da Vinci Firefly Imaging System.
Single-arm, exploratory

Sponsors

Nitta Satoshi
Lead Sponsor
Hiroyuki Nishiyama
Collaborator
Negoro Hiromitsu
Collaborator

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1) Patients diagnosed with primary prostate cancer via histological examination, undergoing robot-assisted radical prostatectomy (RARP). 2) Patients aged between 40 and 80 years at the time of consent acquisition. 3) Patients who have received sufficient explanation about the study, have a thorough understanding, and have provided written consent voluntarily.

Exclusion criteria

Exclusion criteria: 1) Patients with a history of hypersensitivity to ICG. 2) Patients with a history of iodine hypersensitivity. 3) Patients with cT3 4) Patients with a prostate volume exceeding 100 ml or a prostate protrusion into the bladder of 2 cm or more 5) Patients with a history of pelvic surgery or pelvic radiotherapy 6) Patients with neurogenic bladder 7) Patients deemed inappropriate as subjects by the responsible (participating) investigator.

Design outcomes

Primary

MeasureTime frame
The surgeon assesses the usefulness of identifying the bladder-prostate separation line during bladder neck dissection. A 5-point Likert scale is used for evaluation (1: Not useful at all, 2: Not very useful, 3: Neutral, 4: Somewhat useful, 5: Very useful). 1 )Is it useful for determining the line to start the bladder neck incision? 2 )Is it useful for determining the bladder-prostate resection line? 3) Is it useful for more accurately preserving the internal urethral orifice? 4) Is it considered overall useful during bladder neck dissection?

Secondary

MeasureTime frame
1) Time required for bladder neck dissection 2) Safety 3) Usefulness during surgery, such as urethral surrounding dissection (surgeon evaluation) 3-1) Is it a landmark when incising the dorsal vein complex (venous plexus from the penis to the posterior side of the prostate)? 3-2) Is it useful for determining the urethral incision line? 4) Likert scale evaluation by assistants and external evaluators on bladder neck dissection and urethral surrounding dissection 5) Positive rate of bladder neck margin

Contacts

Public ContactNegoro Hiromitsu

University of Tsukuba Hospital

hnegoro@md.tsukuba.ac.jp+81-29-853-3223

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026